Alexium International has announced new roles for several team members as the focus moves to increased commercial product sales across flame retardant (FR) formulations and phase change material (PCM) cooling formulations. The changes will capitalise on the strength of Alexium’s existing management team as Dr. Dirk Van Hyning transitions into the CEO role.
Van Hyning assumes the role of CEO on July 1, 2017.Alexium International has announced new roles for several team members as the focus moves to increased commercial product sales across flame retardant (FR) formulations and phase change material (PCM) cooling formulations. The changes will capitalise on the strength of Alexium's existing management team as Dr. Dirk Van Hyning transitions into the CEO role.#
Van Hyning said, “The planned succession changes enable us to capitalise on our growing reputation and brand awareness in both the FR and PCM markets where end use customers are now requesting environmentally friendly and performance enhancing Alexium formulations, by name.”
Nicholas Clark, currently CEO and executive director, will continue his role on the board as executive director strategy with a focus on strategy beginning July 1 at an adjusted lower salary commensurate with his new duties. In this capacity, Clark will oversee the company’s relations with US Government departments across both defence and commercial sectors and facilitate the company’s anticipated listing on the NASDAQ.
Gavin Rezos, currently executive chairman will transition to non-executive chairman at an adjusted lower salary commensurate with his new duties on July 1. He will retain his current primary responsibility as chairman of the board of directors, overseeing corporate governance and liaising between the board and management.
Aaron Krech, while retaining the role of chief financial officer, will assist Van Hyning by assuming additional responsibility for operational efficiencies throughout the company’s global business and ensuring high-quality customer service. Prior to becoming Alexium’s CFO in 2015, Krech was head of corporate services at Alexium.
Dr. Robert Brookins’s role recently expanded as VP of research and product development, with the consolidation of product development and Research and development into one department, earlier this year. Brookins’ previous work at the Air Force Research Laboratory at Tyndall AFB in Florida, experience in organic synthesis, materials chemistry, and chem/bio protection, are just a few examples of the expertise Brookins brings to this senior position across the full range of products.
Brian Enlow assumed the role of VP of finance earlier this year. Previously Alexium’s financial reporting manager, Brian’s professional background includes public accounting, both audit and taxation, as well as corporate accounting roles focusing on financial reporting and cost accounting.
Nick Clark, CEO of Alexium, said, “One of my main focuses has been placing the right people in the right roles. I am confident that Alexium’s very experienced team will help the company grow in its existing markets while opening up new markets for its specialty chemicals. We have already begun to benefit from this global expansion, with quarterly revenues increasing 92 per cent quarter on quarter in the third quarter of financial year 2017, with higher gross margins each quarter.” (SV)
Fibre2Fashion News Desk – India